Dr. Lal Pathlabs Limited

BSE: 539524 NSE: LALPATHLAB
Dr. Lal Pathlabs Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN L74899DL1995PLC065388 Incorporated 14 February 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - NSE: LALPATHLAB · BSE: 539524 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹2,762.9 Cr
▲ 12.25% YoY
EBITDA · FY 2026
₹883.8 Cr
▲ 12.03% YoY
Net profit · FY 2026
₹509.8 Cr
▲ 3.58% YoY
Authorised capital
₹200 Cr
Registered with MCA
Paid-up capital
₹167.55 Cr
Issued & subscribed
Open charges
₹225.06 Cr
Satisfied ₹343.8 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
4,081
Latest available

About Dr. Lal Pathlabs Limited

Data last updated: 04 January 2026

Dr. Lal Pathlabs Limited is a public limited company based in New Delhi, Delhi, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 14 February 1995, the company has been in operation for over 31 years.

Registered with ROC Delhi under CIN L74899DL1995PLC065388. Listed on BSE: 539524 and NSE: LALPATHLAB.

Capital: an authorised share capital of ₹200 Cr and a paid-up capital of ₹167.55 Cr. Formerly known as Dr. Lal Pathlabs Private Limited. It is led by directors including Arun Duggal and Rahul Sharma.

Last AGM: 28 June 2025. Financial statements filed for year ended 31 March 2025. Office: Block E Sector – 18 Rohini, New Delhi, Delhi, India – 110085.

As per the financials filed for FY 2025, the company reported a revenue of ₹2,554.83 Cr, a growth of 11% compared to the previous year.

The company has a workforce of approximately 4,081 employees as per the latest available data. Its group structure includes 8 subsidiaries.

The company is associated with 1 brand - Dr Lal Pathlabs. As per MCA filings, the company has open charges of ₹225.06 Cr and satisfied charges of ₹343.8 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lalpathlabs.com.

Company Details of Dr. Lal Pathlabs Limited
CIN L74899DL1995PLC065388
Registration Number 065388
Incorporation Date 14 February 1995
ROC Delhi
Listing Status Listed (BSE: 539524, NSE: LALPATHLAB)
Company Status Active
Date of Last AGM 28 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Shankha Banerjee Ceo Arvind Lal Whole-Time Director Vandana Lal Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    lalpathlabs.com
  • Social Media
  • Apps
  • Registered Address
    Block E Sector – 18 Rohini, New Delhi, Delhi, India – 110085
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Dr. Lal Pathlabs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dr. Lal Pathlabs Limited report

Financials, compliance, directors, charges, ownership and filings for Dr. Lal Pathlabs Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74899DL1995PLC065388, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74899DL1995PLC065388 Current
U74899DL1995PTC065388 Previous
U74899DL1995PLC065388 Previous

Associated Brands with Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited operates one associated brand: Dr Lal PathLabs. These brands represent Dr. Lal Pathlabs Limited's diversified market presence and brand portfolio.

Brand Description Website
Dr Lal PathLabs
Chain of pathology and radiology labs lalpathlabs.com

Competitors & Alternatives of Dr. Lal Pathlabs Limited

Brands and companies operating in the same space as Dr. Lal Pathlabs Limited include Redcliffe Labs, Metropolis India, Orange health and 4 more.

Competitor Description Location Founded
Redcliffe Labs Redcliffe Labs Home-based diagnostic tests are booked via an online platform. Noida, India, India 2018
Metropolis India Metropolis India Diagnostic centers are operated as a nationwide chain. Mumbai, India, India 1981
Orange health Orange health At-home diagnostic tests are booked and collected by phlebotomists. Bengaluru, India, India 2020
Agilus Diagnostics Agilus Diagnostics Leading diagnostic chain providing quality blood test and full body checkup services Gurugram, India, India 1995
Apollo Diagnostics Apollo Diagnostics Provides pathology lab tests, health check packages, and home sample collection. Hyderabad, India, India 2015
Sterling Accuris Diagnostics Sterling Accuris Diagnostics Pathology diagnostic services are offered via a chain of labs. Ahmedabad, India, India 2015
Airmed Airmed Provider of a chain of diagnostic labs Ahmedabad, India, India 2016

Business Activity of Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q2 Medical and dental practice, Nursing, pathology, blood bank services, etc. *********

Auditor Details of Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited is audited by Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited is currently managed by 13 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Arun Duggal
Also directs: J B Chemicals And Pharmaceuticals Limited, Dr. Lal Pathlabs Limited, Davenport Management Consultants Services Private Limited
Director 02 Feb 2023 3 Years 5 Months Current
Rahul Sharma
Also directs: Dr. Lal Pathlabs Limited, Porst Ware Llp, Chimes Aviation Private Limited
Director 22 Jul 2005 20 Years 11 Months Current
Gurinder Singh Kalra
Also directs: Dr. Lal Pathlabs Limited
Director 27 Jul 2023 2 Years 11 Months Current
Rajit Mehta
Also directs: Dr. Lal Pathlabs Limited, Max India Limited, Antara Purukul Senior Living Limited and 5 more
Director 27 Jul 2023 2 Years 11 Months Current
Archana Lal Erdmann
Also directs: Dr. Lal Pathlabs Limited, Genecode Health Private Limited
Director 17 May 2019 7 Years 1 Months Current
Shankha Banerjee
Also directs: Dr. Lal Pathlabs Limited, Paliwal Diagnostics Private Limited, Dr. Lal Ventures Private Limited and 4 more
Ceo 21 May 2024 2 Years 1 Months Current
Showing 6 of 13 current directors. View all directors

Financials of Dr. Lal Pathlabs Limited FY 2026 filings available

Dr. Lal Pathlabs Limited reported revenue of ₹2,762.9 Cr (up 12.25% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹2,762.9 Cr ▲ 12.25%
Profit · FY 2026
₹509.8 Cr ▲ 3.58%
EBITDA · FY 2026
₹883.8 Cr ▲ 12.03%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2020: ₹1,330 Cr1,330FY 2020FY 2021: ₹1,581 Cr · +18.9% YoY1,581+18.9%FY 2021FY 2022: ₹2,087 Cr · +32% YoY2,087+32%FY 2022FY 2023: ₹2,017 Cr · -3.4% YoY2,017-3.4%FY 2023FY 2024: ₹2,227 Cr · +10.4% YoY2,227+10.4%FY 2024FY 2025: ₹2,461 Cr · +10.5% YoY2,461+10.5%FY 2025FY 2026: ₹2,763 Cr · +12.2% YoY2,763+12.2%FY 2026
Net Profit₹ Cr · Consolidated0200400600FY 2020: ₹228 Cr228FY 2020FY 2021: ₹297 Cr · +30.3% YoY297+30.3%FY 2021FY 2022: ₹350 Cr · +18.1% YoY350+18.1%FY 2022FY 2023: ₹241 Cr · -31.2% YoY241-31.2%FY 2023FY 2024: ₹362 Cr · +50.3% YoY362+50.3%FY 2024FY 2025: ₹492 Cr · +35.9% YoY492+35.9%FY 2025FY 2026: ₹510 Cr · +3.6% YoY510+3.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0250500750Q1'25: ₹602 Cr · +11.3% YoY602+11.3%Q1'25Q2'25: ₹660 Cr · +9.8% YoY660+9.8%Q2'25Q3'25: ₹597 Cr · +10.7% YoY597+10.7%Q3'25Q4'25: ₹603 Cr · +10.5% YoY603+10.5%Q4'25Q1'26: ₹670 Cr · +11.3% YoY670+11.3%Q1'26Q2'26: ₹731 Cr · +10.7% YoY731+10.7%Q2'26Q3'26: ₹660 Cr · +10.6% YoY660+10.6%Q3'26Q4'26: ₹703 Cr · +16.6% YoY703+16.6%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,762.9 Cr ₹2,461.4 Cr ₹2,226.6 Cr ₹2,016.9 Cr ₹2,087.4 Cr ₹1,581.3 Cr ₹1,330.4 Cr
Other Income ₹101.3 Cr ₹93.4 Cr ₹69.2 Cr ₹41.7 Cr ₹52.5 Cr ₹51.3 Cr ₹55 Cr
Total Income ₹2,864.2 Cr ₹2,554.8 Cr ₹2,295.8 Cr ₹2,058.6 Cr ₹2,139.9 Cr ₹1,632.6 Cr ₹1,385.4 Cr
Cost of Materials Consumed ₹534.6 Cr ₹481.5 Cr ₹451.4 Cr ₹447.2 Cr ₹502.3 Cr ₹397.3 Cr ₹298.7 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹503.3 Cr ₹482.4 Cr ₹424.5 Cr ₹376.5 Cr ₹364.9 Cr ₹273.7 Cr ₹242.6 Cr
Finance Costs ₹22.8 Cr ₹22.3 Cr ₹29.4 Cr ₹37.5 Cr ₹30.2 Cr ₹16 Cr ₹15.3 Cr
Depreciation & Amortisation ₹161.8 Cr ₹141.9 Cr ₹143.6 Cr ₹150.2 Cr ₹108.1 Cr ₹77.2 Cr ₹72.8 Cr
Other Expenses ₹942.5 Cr ₹802 Cr ₹741.4 Cr ₹703.3 Cr ₹659.5 Cr ₹474 Cr ₹445.5 Cr
Total Expenses ₹2,165 Cr ₹1,930.1 Cr ₹1,790.3 Cr ₹1,714.7 Cr ₹1,665 Cr ₹1,238.2 Cr ₹1,074.9 Cr
Profit Before Exceptional Items & Tax ₹699.2 Cr ₹624.7 Cr ₹505.5 Cr ₹343.9 Cr ₹474.9 Cr ₹394.4 Cr ₹310.5 Cr
Exceptional Items -₹30.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹669.1 Cr ₹624.7 Cr ₹505.5 Cr ₹343.9 Cr ₹474.9 Cr ₹394.4 Cr ₹310.5 Cr
Total Tax Expense ₹159.3 Cr ₹132.5 Cr ₹143.2 Cr ₹102.8 Cr ₹124.6 Cr ₹97.9 Cr ₹82.9 Cr
Net Profit ₹509.8 Cr ₹492.2 Cr ₹362.3 Cr ₹241.1 Cr ₹350.3 Cr ₹296.5 Cr ₹227.6 Cr
  attributable to Owners ₹504.8 Cr ₹487.1 Cr ₹357.7 Cr ₹238.9 Cr ₹344.8 Cr ₹291.6 Cr ₹225.9 Cr
  attributable to NCI ₹5 Cr ₹5.1 Cr ₹4.6 Cr ₹2.2 Cr ₹5.5 Cr ₹4.9 Cr ₹1.7 Cr
Other Comprehensive Income ₹5.2 Cr -₹3.6 Cr -₹60 Lakh ₹1.6 Cr -₹1.3 Cr -₹80 Lakh -₹1.1 Cr
Total Comprehensive Income ₹515 Cr ₹488.6 Cr ₹361.7 Cr ₹242.7 Cr ₹349 Cr ₹295.7 Cr ₹226.5 Cr
EBITDA (computed) ₹883.8 Cr ₹788.9 Cr ₹678.5 Cr ₹531.6 Cr ₹613.2 Cr ₹487.6 Cr ₹398.6 Cr
Basic EPS ₹30.24 ₹58.48 ₹43.05 ₹28.82 ₹41.70 ₹35.33 ₹27.42
Diluted EPS ₹30.20 ₹58.40 ₹42.98 ₹28.74 ₹41.57 ₹35.25 ₹27.37
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,146 Cr ₹2,716.8 Cr ₹2,456 Cr ₹2,385.5 Cr
Non-current Assets ₹1,579.4 Cr ₹1,353.3 Cr ₹1,329.3 Cr ₹1,412.5 Cr
Current Assets ₹1,566.6 Cr ₹1,363.5 Cr ₹1,126.7 Cr ₹973 Cr
Property, Plant & Equipment ₹483.8 Cr ₹335.8 Cr ₹343 Cr ₹401 Cr
Inventories ₹43.9 Cr ₹36.1 Cr ₹37.3 Cr ₹33.8 Cr
Trade Receivables ₹110.7 Cr ₹88.1 Cr ₹77.4 Cr ₹70.8 Cr
Cash & Equivalents ₹242.8 Cr ₹292.6 Cr ₹360.9 Cr ₹263.7 Cr
Equity (Net Worth) ₹2,541.3 Cr ₹2,206.5 Cr ₹1,885.4 Cr ₹1,699.5 Cr
Equity Share Capital ₹167.6 Cr ₹83.6 Cr ₹83.5 Cr ₹83.4 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹83.3 Cr
Borrowings (Current) ₹0 ₹0 ₹83.3 Cr ₹153.3 Cr
Total Debt (computed) ₹0 ₹0 ₹83.3 Cr ₹236.6 Cr
Current Liabilities ₹450.7 Cr ₹402.5 Cr ₹465.2 Cr ₹469.8 Cr
Total Liabilities ₹604.7 Cr ₹510.3 Cr ₹570.6 Cr ₹686 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹635.7 Cr ₹568.8 Cr ₹535.4 Cr ₹456 Cr ₹446.7 Cr
Investing Cash Flow -₹421.9 Cr -₹303.1 Cr -₹24.3 Cr -₹287.3 Cr -₹449.2 Cr
Financing Cash Flow -₹263.6 Cr -₹334 Cr -₹413.9 Cr -₹283.2 Cr ₹136.4 Cr
Capital Expenditure ₹167 Cr ₹44.3 Cr ₹51.2 Cr ₹36.5 Cr ₹94.1 Cr
Free Cash Flow (computed) ₹468.7 Cr ₹524.5 Cr ₹484.2 Cr ₹419.5 Cr ₹352.6 Cr
Dividends Paid ₹222.6 Cr ₹207.3 Cr ₹201.2 Cr ₹103 Cr ₹116.7 Cr
Net Change in Cash -₹49.8 Cr -₹68.3 Cr ₹97.2 Cr -₹114.5 Cr ₹133.9 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹702.7 Cr ₹659.8 Cr ₹730.6 Cr ₹669.8 Cr ₹602.6 Cr ₹596.7 Cr ₹660.2 Cr ₹601.9 Cr ₹545.4 Cr ₹538.9 Cr ₹601.3 Cr ₹541 Cr
Other Income ₹24 Cr ₹24.4 Cr ₹24.8 Cr ₹28.1 Cr ₹25.8 Cr ₹25.1 Cr ₹21.9 Cr ₹20.6 Cr ₹18.4 Cr ₹18.3 Cr ₹18.1 Cr ₹14.4 Cr
Total Income ₹726.7 Cr ₹684.2 Cr ₹755.4 Cr ₹697.9 Cr ₹628.4 Cr ₹621.8 Cr ₹682.1 Cr ₹622.5 Cr ₹563.8 Cr ₹557.2 Cr ₹619.4 Cr ₹555.4 Cr
Cost of Materials Consumed ₹135.2 Cr ₹128.7 Cr ₹141.8 Cr ₹128.9 Cr ₹117.8 Cr ₹117 Cr ₹127.3 Cr ₹119.4 Cr ₹108.9 Cr ₹107 Cr ₹122.4 Cr ₹113.1 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹128.8 Cr ₹134.5 Cr ₹132.2 Cr ₹132.3 Cr ₹115.4 Cr ₹126.4 Cr ₹124 Cr ₹116.6 Cr ₹105.4 Cr ₹109 Cr ₹105.4 Cr ₹104.7 Cr
Finance Costs ₹6.1 Cr ₹7.2 Cr ₹4.8 Cr ₹4.7 Cr ₹5 Cr ₹5.3 Cr ₹6 Cr ₹6 Cr ₹6.6 Cr ₹7 Cr ₹7.8 Cr ₹8 Cr
Depreciation & Amortisation ₹44.6 Cr ₹42.1 Cr ₹40.5 Cr ₹34.6 Cr ₹36.4 Cr ₹35.5 Cr ₹35.3 Cr ₹34.7 Cr ₹36.6 Cr ₹36 Cr ₹35.9 Cr ₹35.1 Cr
Other Expenses ₹251.9 Cr ₹217.3 Cr ₹232.5 Cr ₹216.3 Cr ₹200.4 Cr ₹199.3 Cr ₹206.4 Cr ₹195.9 Cr ₹186.4 Cr ₹182.3 Cr ₹195.7 Cr ₹177 Cr
Total Expenses ₹566.6 Cr ₹529.8 Cr ₹551.8 Cr ₹516.8 Cr ₹475 Cr ₹483.5 Cr ₹499 Cr ₹472.6 Cr ₹443.9 Cr ₹441.3 Cr ₹467.2 Cr ₹437.9 Cr
Profit Before Exceptional Items & Tax ₹160.1 Cr ₹154.4 Cr ₹203.6 Cr ₹181.1 Cr ₹153.4 Cr ₹138.3 Cr ₹183.1 Cr ₹149.9 Cr ₹119.9 Cr ₹115.9 Cr ₹152.2 Cr ₹117.5 Cr
Exceptional Items ₹0 -₹30.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹160.1 Cr ₹124.3 Cr ₹203.6 Cr ₹181.1 Cr ₹153.4 Cr ₹138.3 Cr ₹183.1 Cr ₹149.9 Cr ₹119.9 Cr ₹115.9 Cr ₹152.2 Cr ₹117.5 Cr
Total Tax Expense ₹27.9 Cr ₹32.9 Cr ₹51.4 Cr ₹47.1 Cr -₹2.1 Cr ₹40.2 Cr ₹52.3 Cr ₹42.1 Cr ₹34.1 Cr ₹33.7 Cr ₹41.5 Cr ₹33.9 Cr
Net Profit ₹132.2 Cr ₹91.4 Cr ₹152.2 Cr ₹134 Cr ₹155.5 Cr ₹98.1 Cr ₹130.8 Cr ₹107.8 Cr ₹85.8 Cr ₹82.2 Cr ₹110.7 Cr ₹83.6 Cr
  attributable to Owners ₹131.3 Cr ₹90.5 Cr ₹150.6 Cr ₹132.4 Cr ₹154.8 Cr ₹96.7 Cr ₹129.2 Cr ₹106.4 Cr ₹84.5 Cr ₹81.3 Cr ₹109.3 Cr ₹82.6 Cr
  attributable to NCI ₹90 Lakh ₹90 Lakh ₹1.6 Cr ₹1.6 Cr ₹70 Lakh ₹1.4 Cr ₹1.6 Cr ₹1.4 Cr ₹1.3 Cr ₹90 Lakh ₹1.4 Cr ₹1 Cr
Other Comprehensive Income ₹4.3 Cr ₹30 Lakh ₹1.5 Cr -₹90 Lakh -₹2.6 Cr -₹10 Lakh -₹80 Lakh -₹10 Lakh -₹90 Lakh ₹20 Lakh -₹10 Lakh ₹20 Lakh
Total Comprehensive Income ₹136.5 Cr ₹91.7 Cr ₹153.7 Cr ₹133.1 Cr ₹152.9 Cr ₹98 Cr ₹130 Cr ₹107.7 Cr ₹84.9 Cr ₹82.4 Cr ₹110.6 Cr ₹83.8 Cr
EBITDA (computed) ₹210.8 Cr ₹203.7 Cr ₹248.9 Cr ₹220.4 Cr ₹194.8 Cr ₹179.1 Cr ₹224.4 Cr ₹190.6 Cr ₹163.1 Cr ₹158.9 Cr ₹195.9 Cr ₹160.6 Cr
Basic EPS ₹7.86 ₹5.42 ₹18.05 ₹15.88 ₹18.57 ₹11.60 ₹15.52 ₹12.79 ₹10.13 ₹9.77 ₹13.16 ₹9.95
Diluted EPS ₹7.85 ₹5.41 ₹18.01 ₹15.85 ₹18.54 ₹11.58 ₹15.48 ₹12.76 ₹10.12 ₹9.76 ₹13.12 ₹9.93
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,647.6 Cr ₹2,351.6 Cr ₹1,966.8 Cr ₹1,769 Cr ₹1,872.7 Cr ₹1,490.5 Cr ₹1,273.6 Cr
Other Income ₹112.7 Cr ₹111.5 Cr ₹60.1 Cr ₹46.6 Cr ₹53 Cr ₹51.3 Cr ₹57.6 Cr
Total Income ₹2,760.3 Cr ₹2,463.1 Cr ₹2,026.9 Cr ₹1,815.6 Cr ₹1,925.7 Cr ₹1,541.8 Cr ₹1,331.2 Cr
Cost of Materials Consumed ₹508 Cr ₹455.2 Cr ₹390.8 Cr ₹389.6 Cr ₹446.3 Cr ₹373.9 Cr ₹286.9 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹475.2 Cr ₹458.4 Cr ₹363.6 Cr ₹315.5 Cr ₹320.2 Cr ₹257.4 Cr ₹232.1 Cr
Finance Costs ₹22 Cr ₹21.5 Cr ₹26.8 Cr ₹34.4 Cr ₹28.5 Cr ₹14.8 Cr ₹14.7 Cr
Depreciation & Amortisation ₹154.1 Cr ₹134.2 Cr ₹76.5 Cr ₹82.1 Cr ₹75.3 Cr ₹69.8 Cr ₹68 Cr
Other Expenses ₹910.7 Cr ₹772.5 Cr ₹653.2 Cr ₹603.2 Cr ₹596 Cr ₹451.8 Cr ₹426.8 Cr
Total Expenses ₹2,070 Cr ₹1,841.8 Cr ₹1,510.9 Cr ₹1,424.8 Cr ₹1,466.3 Cr ₹1,167.7 Cr ₹1,028.5 Cr
Profit Before Exceptional Items & Tax ₹690.3 Cr ₹621.3 Cr ₹516 Cr ₹390.8 Cr ₹459.4 Cr ₹374.1 Cr ₹302.7 Cr
Exceptional Items -₹30.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹660.2 Cr ₹621.3 Cr ₹516 Cr ₹390.8 Cr ₹459.4 Cr ₹374.1 Cr ₹302.7 Cr
Total Tax Expense ₹152 Cr ₹124 Cr ₹131.6 Cr ₹98.4 Cr ₹115.3 Cr ₹94 Cr ₹79.5 Cr
Net Profit ₹508.2 Cr ₹497.3 Cr ₹384.4 Cr ₹292.4 Cr ₹344.1 Cr ₹280.1 Cr ₹223.2 Cr
Other Comprehensive Income ₹5 Cr -₹3.6 Cr -₹30 Lakh ₹1.9 Cr -₹1.3 Cr -₹70 Lakh -₹1.1 Cr
Total Comprehensive Income ₹513.2 Cr ₹493.7 Cr ₹384.1 Cr ₹294.3 Cr ₹342.8 Cr ₹279.4 Cr ₹222.1 Cr
EBITDA (computed) ₹866.4 Cr ₹777 Cr ₹619.3 Cr ₹507.3 Cr ₹563.2 Cr ₹458.7 Cr ₹385.4 Cr
Basic EPS ₹30.45 ₹59.70 ₹46.25 ₹35.28 ₹41.61 ₹33.93 ₹27.09
Diluted EPS ₹30.40 ₹59.61 ₹46.18 ₹35.17 ₹41.48 ₹33.85 ₹27.04
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,049.2 Cr ₹2,621 Cr ₹2,415.4 Cr ₹2,320.2 Cr
Non-current Assets ₹1,554.6 Cr ₹1,343.7 Cr ₹1,494.9 Cr ₹1,510.1 Cr
Current Assets ₹1,494.6 Cr ₹1,277.3 Cr ₹920.5 Cr ₹810.1 Cr
Property, Plant & Equipment ₹469.4 Cr ₹320.7 Cr ₹294 Cr ₹345.2 Cr
Inventories ₹40.6 Cr ₹32.3 Cr ₹27.5 Cr ₹23.3 Cr
Trade Receivables ₹134.2 Cr ₹105.4 Cr ₹77.8 Cr ₹63.3 Cr
Cash & Equivalents ₹234.4 Cr ₹266.6 Cr ₹325.8 Cr ₹220.3 Cr
Equity (Net Worth) ₹2,472.9 Cr ₹2,134.2 Cr ₹1,899.7 Cr ₹1,689.9 Cr
Equity Share Capital ₹167.6 Cr ₹83.6 Cr ₹83.5 Cr ₹83.4 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹83.3 Cr
Borrowings (Current) ₹0 ₹0 ₹83.3 Cr ₹153.3 Cr
Total Debt (computed) ₹0 ₹0 ₹83.3 Cr ₹236.6 Cr
Current Liabilities ₹434.4 Cr ₹388.5 Cr ₹424.4 Cr ₹432.2 Cr
Total Liabilities ₹576.3 Cr ₹486.8 Cr ₹515.7 Cr ₹630.3 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹605.9 Cr ₹540 Cr ₹477.6 Cr ₹427.6 Cr ₹423.8 Cr
Investing Cash Flow -₹382.1 Cr -₹293 Cr ₹31.8 Cr -₹288.6 Cr -₹448.5 Cr
Financing Cash Flow -₹256 Cr -₹324.8 Cr -₹403.9 Cr -₹270 Cr ₹142 Cr
Capital Expenditure ₹164.4 Cr ₹43.3 Cr ₹44.9 Cr ₹31.7 Cr ₹63.1 Cr
Free Cash Flow (computed) ₹441.5 Cr ₹496.7 Cr ₹432.7 Cr ₹395.9 Cr ₹360.7 Cr
Dividends Paid ₹217 Cr ₹199.9 Cr ₹199.5 Cr ₹99.4 Cr ₹115.7 Cr
Net Change in Cash -₹32.2 Cr -₹77.8 Cr ₹105.5 Cr -₹131 Cr ₹117.3 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹675.2 Cr ₹632.1 Cr ₹699.6 Cr ₹640.7 Cr ₹577.2 Cr ₹528.1 Cr ₹583.9 Cr ₹534.5 Cr ₹479 Cr ₹476 Cr ₹531.7 Cr ₹480.1 Cr
Other Income ₹37 Cr ₹26.6 Cr ₹22.8 Cr ₹26.3 Cr ₹25.2 Cr ₹29.5 Cr ₹22 Cr ₹28.8 Cr ₹15.9 Cr ₹15.1 Cr ₹14.1 Cr ₹15 Cr
Total Income ₹712.2 Cr ₹658.7 Cr ₹722.4 Cr ₹667 Cr ₹602.4 Cr ₹557.6 Cr ₹605.9 Cr ₹563.3 Cr ₹494.9 Cr ₹491.1 Cr ₹545.8 Cr ₹495.1 Cr
Cost of Materials Consumed ₹128.9 Cr ₹121.8 Cr ₹134.7 Cr ₹122.6 Cr ₹111.3 Cr ₹101.9 Cr ₹110 Cr ₹104.9 Cr ₹94.8 Cr ₹92.7 Cr ₹104.3 Cr ₹99 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹121.4 Cr ₹127.4 Cr ₹125.1 Cr ₹125.8 Cr ₹109.4 Cr ₹109.9 Cr ₹107.4 Cr ₹100.8 Cr ₹90.3 Cr ₹93.4 Cr ₹90.1 Cr ₹89.8 Cr
Finance Costs ₹5.9 Cr ₹7 Cr ₹4.6 Cr ₹4.5 Cr ₹4.8 Cr ₹4.8 Cr ₹5 Cr ₹5.5 Cr ₹5.9 Cr ₹6.5 Cr ₹7.1 Cr ₹7.3 Cr
Depreciation & Amortisation ₹42.7 Cr ₹40.1 Cr ₹38.5 Cr ₹32.8 Cr ₹34.6 Cr ₹18.9 Cr ₹18.2 Cr ₹17.8 Cr ₹19.8 Cr ₹19.2 Cr ₹19.1 Cr ₹18.4 Cr
Other Expenses ₹243.4 Cr ₹209.2 Cr ₹224.7 Cr ₹208.9 Cr ₹197.4 Cr ₹170.9 Cr ₹182 Cr ₹173.3 Cr ₹163.6 Cr ₹159.8 Cr ₹174.3 Cr ₹155.5 Cr
Total Expenses ₹542.3 Cr ₹505.5 Cr ₹527.6 Cr ₹494.6 Cr ₹457.5 Cr ₹406.4 Cr ₹422.6 Cr ₹402.3 Cr ₹374.4 Cr ₹371.6 Cr ₹394.9 Cr ₹370 Cr
Profit Before Exceptional Items & Tax ₹169.9 Cr ₹153.2 Cr ₹194.8 Cr ₹172.4 Cr ₹144.9 Cr ₹151.2 Cr ₹183.3 Cr ₹161 Cr ₹120.5 Cr ₹119.5 Cr ₹150.9 Cr ₹125.1 Cr
Exceptional Items ₹0 -₹30.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹169.9 Cr ₹123.1 Cr ₹194.8 Cr ₹172.4 Cr ₹144.9 Cr ₹151.2 Cr ₹183.3 Cr ₹161 Cr ₹120.5 Cr ₹119.5 Cr ₹150.9 Cr ₹125.1 Cr
Total Tax Expense ₹28.8 Cr ₹31 Cr ₹49.1 Cr ₹43.1 Cr -₹3.5 Cr ₹36.7 Cr ₹48.1 Cr ₹38.1 Cr ₹31 Cr ₹31.2 Cr ₹37.9 Cr ₹31.5 Cr
Net Profit ₹141.1 Cr ₹92.1 Cr ₹145.7 Cr ₹129.3 Cr ₹148.4 Cr ₹114.5 Cr ₹135.2 Cr ₹122.9 Cr ₹89.5 Cr ₹88.3 Cr ₹113 Cr ₹93.6 Cr
Other Comprehensive Income ₹4.3 Cr ₹30 Lakh ₹1.3 Cr -₹90 Lakh -₹2.5 Cr -₹20 Lakh -₹1.1 Cr -₹10 Lakh -₹40 Lakh ₹0 -₹40 Lakh ₹50 Lakh
Total Comprehensive Income ₹145.4 Cr ₹92.4 Cr ₹147 Cr ₹128.4 Cr ₹145.9 Cr ₹114.3 Cr ₹134.1 Cr ₹122.8 Cr ₹89.1 Cr ₹88.3 Cr ₹112.6 Cr ₹94.1 Cr
EBITDA (computed) ₹218.5 Cr ₹200.3 Cr ₹237.9 Cr ₹209.7 Cr ₹184.3 Cr ₹174.9 Cr ₹206.5 Cr ₹184.3 Cr ₹146.2 Cr ₹145.2 Cr ₹177.1 Cr ₹150.8 Cr
Basic EPS ₹8.45 ₹5.52 ₹17.46 ₹15.51 ₹17.80 ₹13.74 ₹16.24 ₹14.76 ₹10.73 ₹10.78 ₹13.60 ₹11.28
Diluted EPS ₹8.44 ₹5.51 ₹17.43 ₹15.49 ₹17.78 ₹13.71 ₹16.20 ₹14.73 ₹10.71 ₹10.75 ₹13.57 ₹11.25
Latest 12 quarters shown of 24 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Dr. Lal Pathlabs Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Dr. Lal Pathlabs Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 53.21%, foreign institutional investors hold 17.18%, domestic institutional investors hold 21.38%, retail and other public shareholders hold 7.87% of Dr. Lal Pathlabs Limited. The company had 114,527 shareholders on record.

Promoters: 53.21%DII (Domestic Institutional): 21.38%FII (Foreign Institutional): 17.18%Retail & Others: 7.87%
Mar 2026
QUARTER
53.21% Promoters
21.38% DII (Domestic Institutional)
17.18% FII (Foreign Institutional)
7.87% Retail & Others
Promoter holding - history
Now 53.21% · Mar 2026High 58.70% · Dec 2015Low 53.21% · Sep 2025
52%54%56%58%60%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 58.70%Mar 2016: 58.68%Jun 2016: 58.63%Sep 2016: 58.61%Dec 2016: 58.61%Mar 2017: 58.22%Jun 2017: 57.92%Sep 2017: 57.92%Dec 2017: 57.42%Mar 2018: 57.42%Jun 2018: 57.41%Sep 2018: 57.41%Dec 2018: 56.91%Mar 2019: 56.91%Jun 2019: 56.91%Sep 2019: 56.91%Dec 2019: 56.81%Mar 2020: 56.77%Jun 2020: 56.32%Sep 2020: 55.23%Dec 2020: 55.23%Mar 2021: 55.23%Jun 2021: 55.23%Sep 2021: 55.23%Dec 2021: 55.23%Mar 2022: 55.23%Jun 2022: 55.05%Sep 2022: 55.05%Dec 2022: 55.05%Mar 2023: 55.03%Jun 2023: 55.01%Sep 2023: 54.61%Dec 2023: 54.60%Mar 2024: 54.60%Jun 2024: 54.60%Sep 2024: 53.92%Dec 2024: 53.91%Mar 2025: 53.91%Jun 2025: 53.79%Sep 2025: 53.21%Dec 2025: 53.21%Mar 2026: 53.21%58.70%53.21%53.21%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters53.21%53.21%53.21%53.79%53.91%53.91%
Public46.44%46.44%46.42%45.82%45.83%45.81%
Employee Trusts0.34%0.35%0.37%0.39%0.27%0.28%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters53.21%53.91%54.60%55.03%55.23%55.23%56.77%56.91%57.42%58.22%58.68%
Public46.44%45.83%45.08%44.45%44.07%43.91%42.18%41.89%41.32%39.91%39.44%
Employee Trusts0.34%0.27%0.32%0.51%0.70%0.87%1.04%1.20%1.27%1.86%1.87%
Promoter change (YoY, %pts)-0.70-0.69-0.43-0.20+0.00-1.54-0.14-0.51-0.80-0.46-

Board & Governance of Dr. Lal Pathlabs Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Dr. Lal Pathlabs Limited has 9 directors - 5 independent and 2 executive. The board is chaired by Arvind Lal.

DirectorPositionOn board sinceListed boards
Arvind Lal Executive Director · Chairperson 1995-02-14 1
Archana Lal Erdmann Non-Executive - Non Independent Director 2019-05-17 1
Arun Duggal Non-Executive - Independent Director 2023-02-02 2
Gurinder Singh Kalra Non-Executive - Independent Director 2023-07-27 1
Rahul Sharma Non-Executive - Non Independent Director 2005-07-22 1
Rajit Mehta Non-Executive - Independent Director 2023-07-27 2
Rohit Bhasin Non-Executive - Independent Director 2022-11-08 5
Somya Satsangi Non-Executive - Independent Director 2019-02-08 1
Vandana Lal Executive Director 1995-02-14 1
Board Committees
CommitteeMembers
Audit Committee Rohit Bhasin (Chairperson), Somya Satsangi, Arun Duggal, Archana Lal Erdmann
Nomination and remuneration committee Arun Duggal (Chairperson), Rahul Sharma, Somya Satsangi, Rajit Mehta
Stakeholders Relationship Committee Arun Duggal (Chairperson), Rahul Sharma, Rohit Bhasin
Risk Management Committee Somya Satsangi (Chairperson), Rahul Sharma, Munender Soperna, Rohit Bhasin, Arun Duggal, Shankha Banerjee
Corporate Social Responsibility Committee Arvind Lal (Chairperson), Arun Duggal, Rohit Bhasin

Group Structure of Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited has 8 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Dr. Lal Pathlabs Limited's business expansion strategy and organizational complexity.

8
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Paliwal Diagnostics Private Limited U26914UP1997PTC022257 -
Centrapath Labs Private Limited U74220MP2019PTC049171 -
Dr. Lal Ventures Private Limited U85100DL2018PTC342828 -
Suburban Diagnostics (India) Private Limited U85110MH2002PTC136144 -
Paliwal Medicare Private Limited U85110UP2006PTC031606 -
Aprl Pathlabs Private Limited U85195GJ2019PTC110176 -

Showing major subsidiaries. Total: 8.

Charges & Borrowings of Dr. Lal Pathlabs Limited

Open charges
₹225.06 Cr
Satisfied charges
₹343.8 Cr
Breakdown by lending institutions
Axis Bank Limited₹185.00 Cr
Others₹40.00 Cr
State Bank of Baroda₹0.06 Cr
Latest charge details
DateLenderAmountStatus
10 Nov 2021 Others ₹40 Cr Open
09 Nov 2021 Axis Bank Limited ₹185 Cr Open
19 Apr 1988 State Bank of Baroda ₹6.13 Lakh Open
24 Jun 2022 Hdfc Bank Limited ₹250 Cr Satisfied
07 Dec 2020 Others ₹10 Cr Satisfied

Total charge records: 17 View all charges

Employees and EPFO Compliance at Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited has a workforce of 4,081 employees as of Apr 01, 2024.

Employee count
4,081
Active EPFO establishments
3
Employee growth
-0.1%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Dr. Lal Pathlabs Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Dr. Lal Pathlabs Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Dr. Lal Pathlabs Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Dr. Lal Pathlabs Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Dr. Lal Pathlabs Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Dr. Lal Pathlabs Limited

MSME Payment Delays by Dr. Lal Pathlabs Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Dr. Lal Pathlabs Limited

Subsidiaries & Group Companies of Dr. Lal Pathlabs Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Dr. Lal Pathlabs Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Dr. Lal Pathlabs Limited

MCA Filings & Documents of Dr. Lal Pathlabs Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Dr. Lal Pathlabs Limited

Activity
28 Jun 2025
Dr. Lal Pathlabs Limited last Annual general meeting of members was held on 28 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Dr. Lal Pathlabs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
10 Mar 2025
A charge registered on 24 Jun 2022 via Charge ID 100594143 with Hdfc Bank Limited was fully satisfied on 10 Mar 2025.
Directors
30 May 2024
Shankha Banerjee was appointed as a Ceo on 30 May 2024 & has been associated with this company since 2 years 1 month.
Directors
21 May 2024
Shankha Banerjee was appointed as a CEO on 21 May 2024 & has been associated with this company since 2 years 1 month.
Directors
27 Jul 2023
Gurinder Singh Kalra was appointed as a Director on 27 Jul 2023 & has been associated with this company since 2 years 11 months.

Recent News on Dr. Lal Pathlabs Limited

Stocks that will see action today January 30, 2025
30 Jan 2025 · Thehindubusinessline

Frequently Asked Questions about Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 14 February 1995 (31+ years old) and is registered under CIN L74899DL1995PLC065388. Listed on BSE: 539524 and NSE: LALPATHLAB. The company has 4,081 employees.

Dr. Lal Pathlabs Limited reported revenue of ₹2,554.83 Cr for FY 2025 (up 11.00% YoY).

The current directors of Dr. Lal Pathlabs Limited are:

The primary industry of Dr. Lal Pathlabs Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes. Dr. Lal Pathlabs Limited is listed on both BSE (code: 539524) and NSE (symbol: LALPATHLAB).

Dr. Lal Pathlabs Limited can be reached at the registered office: Block E Sector – 18 Rohini, New Delhi, Delhi, India – 110085, or through the website lalpathlabs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available